Background Pain from advanced cancer remains prevalent, severe and often under-treated. Aim The aim of this study was to conduct a discrete choice experiment with patients to understand their preferences for pain management services and inform service development. Methods Focus groups were used to develop the attributes and levels of the discrete choice experiment. The attributes were: waiting time, type of healthcare professional, out-ofpocket costs, side-effect control, quality of communication, quality of information and pain control. Patients completed the discrete choice experiment along with clinical and health-related quality of life questions. Conditional and mixed logit models were used to analyse the data. Results Patients with cancer pain (n = 221) and within palliative care services completed the survey (45% were female, mean age 64.6 years; age range 21-92 years). The most important aspects of pain management were: good pain control, zero out-of-pocket costs and good side-effect control. Poor or moderate pain control and £30 costs drew the highest negative preferences. Respondents preferred control of side effects and provision of better information and communication, over access to certain healthcare professionals. Those with lower health-related quality of life were less willing to wait for treatment and willing to incur higher costs. The presence of a carer influenced preferences. Conclusions Outcome attributes were more important than process attributes but the latter were still valued. Thus, supporting self-management, for example by providing better information on pain may be a worthwhile endeavour. However, service provision may need to account for individual characteristics given the heterogeneity in preferences.
analgesic ladder approach to interventions, a European survey of 5000 cancer patients found that 72% still experienced pain, 90% of which was of moderate-to-severe intensity [1] . Elsewhere, a US study found that 33% of cancer patients experiencing pain were receiving inadequate analgesic prescriptions [2] . Evidently, cancer pain is not being managed optimally [3] , compromising the quality of life of patients [4, 5] and leading to greater healthcare costs, for example through increases in emergency admissions [6] .
Most patients with advanced cancer prefer to be cared for at home and to die at home [7] . Current National Health Service policy in England advocates a multidisciplinary approach to the management of patients with advanced disease that prioritises pain and symptom management [8] . However, one UK regional study showed that poor pain control is the most frequent reason that cancer patients at home request urgent medical help [9] . This suggests that current service provision is not adequate and that improved support for community-based self-management of cancer pain is needed. Improving the Management of Pain from Advanced Cancer in the Community (IMPACCT) is a UK research programme aimed at facilitating this [10] .
Eliciting patient preferences is important in clinical service design [11, 12] . Stated preference survey techniques such as discrete choice experiments (DCEs) and best-worst scaling surveys are increasingly being used to understand what is important to patients, particularly those with cancer [13, 14] . Preference elicitation techniques are important in economics because they force respondents to weigh up the costs and benefits of possible alternatives and to make choices and trade-offs. In doing so, a closer approximation of how much 'value' respondents really place on the options and their attributes is gained compared with simply asking them what their preferences are [15] .
Several studies have established preferences for cancer treatments (e.g. [16] ), pain care services [17] , and to determine the trade-offs between pain control and side effects [18, 19] . However, only one (US-based) study has been conducted solely with cancer patients to understand their preferences for pain management [20] . This study found that the most important aspect of analgesic treatment for patients was 'percent pain relief with analgesics' [20] . The findings have limited value for service planning as the study did not go beyond opioid treatments to consider preferences for wider aspects of pain management, which are more related to the process of care such as information, waiting times, and the type of healthcare professional providing care.
The aim of this research was to address this knowledge gap by conducting a preference survey exclusively with cancer patients experiencing pain in England. The survey sought to establish which aspects of pain management are most important to patients and their willingness to trade off between these to inform future service development policies.
Methods

Design
We conducted a DCE survey where respondents were presented with two unlabelled descriptions of hypothetical pain management services. The descriptions convey different service 'attributes' (e.g. 'contact with GP') and 'levels' (e.g. 'Weekly phone call' vs. 'Monthly visit') within each attribute [14] . Respondents are asked to consider the pain management service descriptions and choose which they would prefer to receive. In making their choices, respondents are assumed to estimate which would yield the overall greatest utility (or value) for them. Respondents complete several of these 'choice tasks' in the survey where some or all of the levels of options are altered. By observing participants' responses to changes in the options, it is possible to quantify the relative strength of preference for the different attributes and levels presented and the willingness to trade off between them.
Attribute Development
We followed guidance for the DCE design and development by incorporating qualitative research [21] . We generated the content of the DCE survey through a literature review and focus group (n = 2) work with patients (n = 10; 40% were male, median age 70 years; age range 48-86 years) with pain from advanced cancer who attended one of two hospices in Leeds. A topic guide (included in the Supplementary Material) was developed following a scoping review and discussion with clinicians and used to facilitate the focus groups. Patients were asked to talk about their cancer pain, how well it was controlled, important aspects of pain management, the care they received and any service improvements they would like to see. Focus groups were audio recorded, transcribed verbatim and analysed by two researchers using thematic analysis following the recommendations set by Braun and Clarke with the aim to identify key themes [22] . The transcripts were managed in NVivo (QSR International Pty Ltd, Melbourne, Victoria, Australia). Key themes identified by the qualitative analysis of the focus groups included the supply of pain medications, the role of day centres/hospices, access to medications and education on morphine use (see the Supplementary Material for a summary of the full results). A long list of 16 attributes (Supplementary Table A ) was arrived at via consensus meetings between researchers, clinicians and nurses after discussion of the focus group results. A ranking exercise was conducted with a group of healthcare professionals (n = 24) to reduce the list to a practicable number and to suggest attribute levels. A meeting was held with the healthcare professionals and they were presented with, and allowed to discuss, the draft attributes. They were then asked individually to rank order the eight attributes they felt were most important to patients. The ranking scores, focus group material and additional clinical expertise were used to refine the attributes including the collapsing and removal of some. The levels for out-of-pocket costs were informed by a previous feasibility survey covering healthcare resource use and patient costs completed in this patient group and part of the same research programme. Of the final seven attributes, four comprised three levels and three comprised two levels. The language of the final attributes and levels (shown in Table 1 ) were tested with patients prior to the main survey.
Discrete Choice Experiment Survey
Ngene software (Version 1.1.1; ChoiceMetrics Pty Ltd, Sydney, NSW, Australia) was used to create an efficient design of the DCE survey by maximizing D-efficiency. The design resulted in 36 binary choice sets that were divided into six blocks of six choice sets each. Each of the choice sets had all of the attributes present and all of the levels were represented but in different combinations across the six sets. Priors were not included in the design and, because there was no strong expectation of heterogeneity, interactions were also omitted. Each respondent was randomly allocated one block consisting of six choice tasks. In addition to the choice tasks, respondents completed sociodemographic questions, cancer-and pain-related questions, and the EQ-5D-3L questionnaire [23] .
Sampling
Community-based patients with pain from advanced cancer who were aged 18 years and over were eligible for the study. Advanced cancer was defined as metastatic cancer or that receiving palliative therapy. Patients with pain were defined as those receiving analgesic treatment for cancer symptom-or therapy-related pain. Patients had to be able to complete the questionnaires and provide informed consent to participate. Patients completed the DCE in a pen and paper format with the research nurse present to help provide clarification if necessary. Thirteen palliative care services across England recruited patients to the study. Prespecifying the required sample size for a DCE is complex, relying as it does on a priori knowledge of the parameters to be estimated in the models [24] . However, based on previous experience, we were confident that a sample of n = 200 (assuming seven attributes each with three or fewer levels and six choice task completions by each respondent) would provide sufficient data to estimate robust models. Ethical approval was granted by the National Research Ethics Service Committee South East Coast, Brighton and Sussex (Reference: 13/LO/0662).
Analysis
The data was analysed using conditional and mixed logit models. The size and direction of the coefficient indicated the importance of that level in determining the choice of the individual and can be considered to represent preference weights [14] . The model coefficients were used to provide marginal rates of substitution between different pain management attributes, denoting respondents' willingness to 'trade off'. To facilitate this, the levels of two attributes (outof-pocket costs and waiting time) were entered into the model as continuous variables. The central value of the range was taken as the value for waiting time. The 'out-of-pocket costs' attribute was used as the subjective valuation mechanism; however, we acknowledge the values produced may not reflect willingness to pay for services. All other explanatory variables were treated as categorical and dummy coded in the analysis. Interactions were tested between attribute levels and sub-groups to test for heterogeneity of preferences. The sub-groups tested were: age group (above/below median of 66 years); sex; whether patients had an informal carer (defined as completion of a carer questionnaire) or not; cancer duration groups (above/below median of 1.5 years); pain severity groups (mild vs. moderate/severe); pain relief groups (\70% vs. C70%); EQ-5D groups (above/below median of 0.52); and healthcare cost groups (above/ below median monthly cost of £430). We also ran a model using effects coding [25] for categorical variables; as this provides a coefficient for all levels, we can illustrate the preference change with each level. The mixed logit model informed on the level of unobserved heterogeneity in the preferences; we assumed this was present in all parameters and tested this by allowing all to be random in the analysis. Relative model quality was judged using Akaike and Bayesian information criterion values. All analyses were conducted in Stata (StataCorp LLC, College Station, TX, USA).
Results
Patient Sample
Two hundred and forty-eight patients were recruited and completed the survey. There were some missing data with 27 (10.9%) completing the resource use and quality-of-life sections of the survey but not attempting the DCE section. There were 3% missing or spoilt responses from those who did complete the DCE section. Pearson Chi-squared tests indicated that non-completion of the DCE was not related to sex or pain severity but there was a trend that those in the older age group (over 66 years) were less likely to complete the survey (p = 0.032). Those whose highest level of education was secondary school also appeared more likely to not complete the DCE than those who received a college or university education (p = 0.002). The sample characteristics are included in Table 2 . Almost all participants were white but there was a good distribution across pain severity and EQ-5D scores. See the Supplementary Material for block completion samples.
Discrete Choice Experiment Analysis
Results of the conditional logit model and mixed logit model are included in Table 3 .
Conditional Logit
Squared terms for the waiting time and cost attributes were not significant and excluded from the final model. The model and coefficients were significant with all the estimated preference coefficients being negative. Thus, less desirable levels were associated with reduced utility, which indicated that the survey had theoretical validity. The ordering of the level coefficients for the pain control attribute was also as anticipated: moderate pain control was worse than good control, and poor pain control was worse still. Limited non-satiation tests were possible owing to the survey design but indicated that only 2.7% of people provided an irrational response (in 36 choices).
Preference weights for the levels with effects coding are shown in Fig. 1 . The greatest preference was for good pain control with lower levels of positive preferences for immediate service (0 waiting time), seeing a specialist pain doctor, incurring no out-of-pocket costs, having good side-effect control, and good communication and information. By some margin, the level leading to the greatest utility decrement was poor pain control, followed by an out-of-pocket expense of £30 and then moderate pain control. We conducted an exploration of dominance in responses and did find evidence for this. For example, 33.5% of respondents always chose the option where pain control was better, compared with 4% always choosing an option based on waiting time.
A number of the interactions between attribute level and respondent characteristic were significant (see Supplementary Table B ). Male individuals were more averse to poor side-effect control than female individuals (p = 0.042). Those with lower EQ-5D scores were less willing to accept poorly controlled side effects (p = 0.026), less willing to wait for treatment (p = 0.002) and willing to incur higher out-of-pocket costs (p = 0.021) in receiving pain management. Those who had cancer for longer were more averse to severe pain (p = 0.036), perhaps reflecting real experiences of sub-optimal management. There also appeared to be some heterogeneity according to the level of support an individual had as those who had a carer were more likely to accept pain management by a general practitioner (GP) (p = 0.017) and willing to incur higher out-of-pocket costs (p = 0.007) than those without a carer. Interactions with pain level (mild vs. moderate or severe) were largely insignificant although, counter-intuitively, those who had mild pain were more averse to waiting for treatment. A finding more in line with expectations was that those with poor pain relief (\70%) were less willing to wait for treatment.
Mixed Logit
The mixed logit model appeared to improve fit statistics; however, preference weights were very similar to those for the conditional logit model (Table 3 ). Notable differences were an increased disutility associated with specialist pain nurse care, poor side-effect control and poor information in the mixed logit model. This model also had the effect of decreasing the disutility associated with moderate pain control and increasing it slightly for poor pain control. The results indicated that there may be significant heterogeneity in four parameters: waiting time, out-of-pocket costs, communication and good pain control. Although on average patients preferred lower wait times, lower cost, good communication and good pain control, the results suggest there may have been some heterogeneity present. From the magnitudes of the mean estimates and the corresponding standard deviations, z scores (standard normal distribution) were calculated and indicate that 8% preferred longer waiting times, 14% preferred higher costs, 8% preferred poor communication and 3% did not prefer good pain control.
We calculated willingness to wait and pay based on mixed logit models by keeping the cost or wait time as fixed (and all others random). Table 4 includes the trade-offs in the form of willingness to wait and pay for the different pain management attributes based on the mixed logit results. On average, patients valued a reduction of 1 day in waiting time as equivalent to £7.72. This may also be interpreted as meaning that patients were willing to incur costs of £7.72 to avoid waiting a day for treatment. Similarly, patients valued seeing a specialist pain doctor rather than a GP as equivalent to £23.80 and good side-effect control, good information and communication (vs. poor) were valued between £27 and £35. Avoiding poor pain control was highly valued at around £83 per month. When the trade-off was between the waiting time and the rest of the treatment aspects, patients would be willing to wait 3.26 days longer to see a specialist pain doctor rather than a GP and approximately an additional 3.5 to 4.5 days to achieve good side-effect control and to receive good information and communication. Willingness to wait for good pain control (vs. poor) was much higher, an average of just over 11 days. 
Discussion
We found that the most important aspects of pain management were good pain control, incurring zero out-ofpocket costs and good control of side effects. Poor and moderate pain control and £30 out-of-pocket costs drew the highest negative preference weights. There was little evidence that patients were willing to trade pain outcomes for aspects of process (or health for process utility), as the pain attribute was much more important than the others presented. However, the other outcome attribute (control of side effects) was much less powerful and good side-effect control yielded preference weights similar to receiving good information about pain management and seeing a specialist pain doctor. Previous studies have suggested the negative impact of analgesic side effects was significant and that patients would often trade off pain control against the side effects of pain medications. For example, Chancellor et al. [18] found pain impact was second in importance to nausea side effects in their DCE and Gregorian et al. [19] found that both chronic and acute pain patients rated avoiding vomiting as more important than pain relief; nausea was almost as important. These findings are echoed elsewhere, although Meghani and colleagues found it was the type of side effect (with nausea and vomiting being the worst) that was more important than its severity [20] . In general, patients preferred to be seen by a healthcare professional other than a GP; this may be a real preference reflecting experiences but may have been influenced by the level descriptors of 'specialist' pain doctor or nurse for the other two attribute levels. The preference weights suggest that, while respondents preferred immediate treatment with zero out-of-pocket costs, they were willing to wait a few days for treatment and incur some costs (£10). Respondents were willing to incur costs from £23.80 to £34.42 to reduce waiting time by 4 days, receive good information and communication (vs. poor), and to see a specialist pain doctor (rather than a GP). However, they were willing to incur costs over £83 to receive good pain control. For the superior attribute levels, patients were willing to wait around 4 days but would wait over 11 days for good pain control (vs. poor).
A number of the interaction effects were significant suggesting pain management preferences depend on patient characteristics and circumstances, especially patients' level of health-related quality of life and whether they have an informal carer or not. Several of these effects appear to provide evidence of the internal validity of the DCE. For example, those with lower health-related quality of life were less willing to wait for treatment and willing to incur higher out-of-pocket costs. The mixed logit results also indicate significant heterogeneity in preferences for several of the service aspects. For a small minority, there was a suggestion of counter-intuitive preferences (e.g. prefer longer wait times for treatment); this may be because of a lack of participant understanding or engagement or the result of an artefact of the survey design.
Strengths and Limitations
This is the most in-depth study to date employing stated preference techniques to elicit the preference of cancer patients in palliative care for pain management. The use of DCE methodology enabled the capture of 'process' utility; the value placed on services and interventions that is not readily measurable by the standard quality-adjusted lifeyear approach [26, 27] . For example, feeling confident about how much morphine to take may have little value in the quality-adjusted life-year framework, but here was shown to be important to patients in terms of the value placed on good information. While overwhelmingly patients preferred positive pain outcomes, it was clear that people also valued process aspects of service including good information and communication.
While the design of the survey was based on patient input, the sample size for the qualitative aspect of the study was probably below the optimal. In addition, we relied in part on healthcare professionals to inform attribute selection and this may have led to a different DCE design than had we relied solely on patients. However, the substantial breadth and depth of experience that the healthcare professionals brought was valuable and the survey was checked with patients prior to being finalised. As the survey sample were almost all white and because those who completed the survey had higher levels of education than those who did not, the generalizability of the findings to other groups requires some caution. We did not test patient's understanding of the DCE method, although the survey was carefully explained to individuals. Caution is required in interpreting the 'willingness to pay' values for two reasons; these values were based on a 'costs incurred' attribute and they are influenced by the expectations of the respondents. Thus, as healthcare is free at the point of use in England, these values may not represent the willingness to pay should patients be required to pay but, rather, where healthcare is 'free', they represent the willingness to incur costs in accessing that care. Thus, the values may not be generalizable to other types of healthcare systems. However, they still highlight the importance of out-of-pocket costs for patients. Finally, as in all stated preference studies, the caveat must be applied that the responses may neither accurately reflect true preferences nor reflect well the actual choice behaviour by patients in reality [28] . However, in the absence of demand information for new services, it is likely that the preferences provided by such surveys can still improve decision making overall. Future research could explore the use of stated preference techniques alongside economic evaluations to determine the cost per quality-adjusted life-year of each attribute and level and enable the identification of services that meet demand but are also cost effective. This may face several challenges, not least the issue of who should value services and interventions, the patient or the general population [29] . Additional research is also required to establish the external validity of the survey predictions if they are to be the basis for decision making.
Implications for Clinical Practice
Not surprisingly, good pain control was the most important factor in pain management preferences. However, patients also valued good information and communication, and control of side effects. Providing information such that the patient has increased confidence in taking analgesics, or providing continuity of care, for example, may be relatively low cost routes to improving services. General practitioners were the least preferred healthcare professional; however, the preference for information and communication outweighed that for certain healthcare professionals. These findings suggest that supporting self-management of cancer pain (for example, better information on pain, medicines management, dealing with side effects) would be valued by patients. High out-of-pocket costs might deter treatment seeking for patients at the end of life and hence should be minimised where possible. The heterogeneity in results also suggests particular attention should be focused on those with the lowest health-related quality of life and on those who do not have an informal carer. These groups of patients may feel less supported and have different preferences for care, particularly for more prompt responses by healthcare professionals. Thus, service development must allow for the heterogeneity in preferences and be sensitive to personal factors and health status, especially when choices are offered.
Conclusions
The preferences for pain management in advanced cancer were strongest for outcomes but aspects of the process of care were also valued. Thus, while pain control should remain the focus, supporting self-management, for example by providing better information on pain may be a worthwhile endeavour. However, service provision may need to account for individual characteristics given the heterogeneity in preferences.
